LFF571: Clinical Trials

1 trial of LFF571, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow LFF571: new trials by email Literature Review of LFF571 trials Research Report on LFF571

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of Multiple Daily Dosing of Oral LFF571 in Patients With Moderate Clostridium Difficile Infections
LFF571, Vancomycin (POC) - Moderate Clostridium Difficile Infection
Phase 2CompletedNovartis Pharmaceuticals1092010-10-012020-12-19

Conditions studied

Enterocolitis, Pseudomembranous (1)

Sponsors

Novartis Pharmaceuticals (1)

Countries

Canada (1)  ·  United States (1)

Results publications

PMID 25534724, PMID 25534727